These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 6982748)

  • 1. Studies with multiple markers on malignant lymphomas and lymphoid leukemias.
    Watanabe S; Shimosato Y; Shimoyama M; Minato K
    Cancer; 1982 Dec; 50(11):2372-82. PubMed ID: 6982748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic classification of leukemia and lymphoma.
    Foon KA; Todd RF
    Blood; 1986 Jul; 68(1):1-31. PubMed ID: 2941082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunological classification of lymphoma and lymphocytic leukemias (author's transl)].
    Derre M; Tubiana N; Carcassonne Y
    Sem Hop; 1980 Dec 18-25; 56(47-68):1999-2003. PubMed ID: 6256913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A unique cell surface antigen identifying lymphoid malignancies of B cell origin.
    Nadler LM; Ritz J; Hardy R; Pesando JM; Schlossman SF; Stashenko P
    J Clin Invest; 1981 Jan; 67(1):134-40. PubMed ID: 6969730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoid leukemia and non-Hodgkin's lymphoma type continuum, superimposed to lymphocyte differentiation step continuum. A proposition for a revised W. H. O. lympiioid leukemia-lymphoma categorisation.
    Mathé G
    Biomed Pharmacother; 1985; 39(3):109-14. PubMed ID: 3864494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients.
    Habeshaw JA; Catley PF; Stansfeld AG; Brearley RL
    Br J Cancer; 1979 Jul; 40(1):11-34. PubMed ID: 314300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Classification of non-Hodgkin's lymphomas on the basis of Morphological and immunological features shared by normal and neoplastic lymphatic cells (author's transl)].
    Stein H
    Immun Infekt; 1976 Apr; 4(2):52-69. PubMed ID: 1085745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etiological, clinical and prognostic significance of the T-B immunological classification of primary acute lymphoid leukemias and non Hodgkin's lymphomas.
    Belpomme D; Lelarge N; Mathé G; Davies AJ
    Haematol Blood Transfus; 1977; 20():33-45. PubMed ID: 305400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic approach to non-Hodgkin lymphomas and related leukemias. Analysis of the results of multiparameter studies of 425 cases.
    Lukes RJ; Parker JW; Taylor CR; Tindle BH; Cramer AD; Lincoln TL
    Semin Hematol; 1978 Oct; 15(4):322-51. PubMed ID: 366759
    [No Abstract]   [Full Text] [Related]  

  • 10. Heterogeneity of marker expression in B-cell leukemias and its diagnostic significance.
    Menon M; Drexler HG; Minowada J
    Leuk Res; 1986; 10(1):25-8. PubMed ID: 3080642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell lymphomas.
    Wright DH
    Histopathology; 1986 Mar; 10(3):321-6. PubMed ID: 3516842
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunologic characterization and ultrastructural correlations for 125 cases of B- and T-cell leukemias: studies of chronic and acute lymphocytic, prolymphocytic, lymphosarcoma cell and hairy cell leukemia, Sézary's syndrome, and other lymphoid leukemias.
    Said JW; Pinkus GS
    Cancer; 1981 Dec; 48(12):2630-42. PubMed ID: 6975649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Ia-like antigen in lymphatic leukaemias and non-hodgkin lymphomas in correlation with other surface markers.
    Bergmann L; Mitrou PS; Cherdron T; Holloway K; Jost J; Timm V; Zerth G
    Scand J Haematol; 1982 Sep; 29(3):224-34. PubMed ID: 6983113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic markers for classification of leukemias and non-Hodgkin lymphomas.
    Thierfelder S; Rodt H; Thiel E; Hoffmann-Fezer G; Netzel B; Haas RJ; Wündisch GF; Bender-Götze C
    Recent Results Cancer Res; 1979; 69():41-8. PubMed ID: 382307
    [No Abstract]   [Full Text] [Related]  

  • 15. Monoclonal antibody studies in B(non-T)-cell malignancies.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
    Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers).
    Al Saati T; Laurent G; Caveriviere P; Rigal F; Delsol G
    Clin Exp Immunol; 1984 Dec; 58(3):631-8. PubMed ID: 6239721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane cell markers in human leukemias and lymphomas.
    Seligmann M
    Ric Clin Lab; 1976; 6(2):93-8. PubMed ID: 1087994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunologic phenotyping of cutaneous lymphomas].
    Kaudewitz P; Burg G; Smolle J; Braun-Falco O
    Hautarzt; 1986 Dec; 37(12):647-55. PubMed ID: 2880828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic markers in non-Hodgkin's lymphoma.
    Freedman AS; Nadler LM
    Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell markers in lymphomas and leukemias.
    Bowman WP; Melvin S; Mauer AM
    Adv Intern Med; 1980; 25():391-425. PubMed ID: 6987847
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.